MC2 Therapeutics A/S, an emerging pharmaceutical company developing next generation patient-friendly topical therapies for skin and eye diseases, announced the...
Novartis has presented new Cosentyx (secukinumab) data from the prospective the Phase III SCALP study which showed significant improvement in...
Dignitana, a world leader in medical scalp-cooling technology, announced that the FDA has granted the company’s de novo application to...